Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Hemorrhage 13Neoplasms 7Leiomyoma 6Breast Neoplasms 6Hematologic Neoplasms 4Thrombocytopenia 3Postoperative Hemorrhage 3Meningioma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Seroma 2Prostatic Neoplasms 2Ovarian Neoplasms 2Myofibroma 2Head and Neck Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Blood Loss, Surgical 2Wrist Fractures 1Urologic Diseases 1Urinary Retention 1Thromboembolism 1Skin Neoplasms 1Seizures 1Sarcoma 1Recurrence 1Postoperative Complications 1Polyposis, Gastric 1Pituitary Neoplasms 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6relugolix 5Norethindrone Acetate 5vilaprisan 4Uterine Myomectomy 4Uterine Artery Embolization 4linzagolix 2ulipristal acetate 1ulipristal 1pycnogenols 1Tranexamic Acid 1Radiofrequency Ablation 1Progesterone 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Ibuprofen 1Hysterectomy 1Endomet 1Electrocoagulation 1Cryosurgery 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Menorrhagia × Tranexamic Acid × Clear all
NCT03317795 2021-12-08

Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids

Mayo Clinic

Phase 4 Completed
18 enrolled 13 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡